Risks of transplanting kidneys from hepatitis B surface antigen- negative, hepatitis B core antibody-positive donors

Transplantation

Volumn 64, Issue 3, 1997, Pages 432-435

  Satterthwaite, Roger ^a   Ozgu, Isik ^a   Shidban, Hamid ^a   Aswad, Saleh ^a   Sunga, Victor ^a   Zapanta Jr , Ramulfo ^a   Asai, Paul ^a   Bogaard, Thomas ^a   Khetan, Umakant ^a   Mendez, Rafael G ^a   Mendez, Robert ^a  

^a National Institute of Transplantation Los Angeles   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HUMAN; INFECTION RISK; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROCONVERSION; SURVIVAL RATE;

ADULT; CADAVER; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0030799619     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708150-00011     Document Type: Article

References (25)

1. Antoine C, Bedrossian J, Binet I, et al Follow-up of renal allograft recipients from HBsAg donors. Transplant Proc 1995; 27: 1725.
2. Bedrossian J, Akposso K, Metvier F, et al. Kidney transplantations with HBsAg+ donors. Transplant Proc 1993; 25: 1481.
3. Chan MK, Chang WK. Renal transplantation from HBsAg positive donors to HBsAg negative recipients. BMJ 1988; 297: 522.
4. Wolf JL, Perkins HA, Schreeder MT, Vincenti F The transplanted kidney as a source of hepatitis B infection. Ann Intern Med 1979; 91: 3.
5. Hoofnagle JH, Schafer DF. Serological markers of hepatitis B virus infection. Semin Liver Dis 1986; 6: 1.
6. Krugman S, Overby LR, Mushawar IK, et al. Viral hepatitis type B. N Engl J Med 1979 300: 101.
7. Douglas DD, Rakela J, Mamish D, et al. Transmission of hepatitis B virus (HBV) from orthotopic donor livers [Abstract]. Hepatology 1992; 16: 49A.
8. Brechot C, Degos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985; 312: 270.
9. Brechot C, Kremsdorf D, Paterlini P, Thiers V. Hepatitis B virus DNA in HBsAg-negative patients: molecular characterization and clinical implications. J Hepatol 1991; 13 (suppl 4): 49.
10. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 3: 142.
11. Degos F, Lugassy C, Degott C. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients. Gastroenterology 1988; 94: 151.
12. Wachs ME, Amend WJ, Ascher NL, et al The risk of transmission of hepatitis B from HBsAg(-), HBcAb (+), HBIgM (-) organ donors. Transplantation 1995; 59: 230.
13. Hoofnagle JH, Gerety RI, Ni L, Barker LF. Antibody to hepatitis B core antigen. N Engl J Med 1974; 290: 1336.
14. Krugman S, Hoofnagle JH, Gerety RJ. Viral hepatitis type B: DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med 1974; 290: 1331.
15. Hoofnagle JH, Seef LB, Bales ZB, et al. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antibody. N Engl J Med 1978; 298: 1379.
16. Kitchen AD, Harrison TJ, Meacock TJ, et al. Incidence and significance of HBcAb in a healthy blood donor population. J Med Virol 1988; 25: 69.
17. Perillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibodies to human immunodeficiency virus. Ann Intern Med 1986; 105: 382-3.
18. Locasciulli A, Santamaria M, Masera G, et al. Hepatitis B markers in children with acute leukemia. J Med Virol 1985; 15: 29.
19. Parfey PS, Forbes RDC, Hutchinson TA, et al. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 1984; 37: 461.
20. Parfey PS, Forbes RDC, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
21. O'Grady JG, Sutherland S, Harvey F, et al. Cytomegalovirus infection and donor/recipient HLA antigens. Lancet 1988; 11: 302.
22. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled trial in a high risk population in the United States. N Engl J Med 1980; 303: 833.
23. Cattral MS, Krajden M, Wanless IR. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996; 61: 1483.
24. Naumova AK, Kisselev LL. Biological consequences of interactions between hepatitis B virus and human nonhepatic genomes. Biomed Sci 1990; 1: 233.
25. Yoffe B, Burns DK, Bhatt HS, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 1990; 12: 187.